Since Vioxx scare, tough times for industry R&D, study finds
December 01 2011
A review of 450 New Molecular Entities spanning a decade and a half found two distinct eras of drug R&D ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.